iShares U.S. Healthcare ETF News - September 20, 2026

Ultragenyx Wins FDA Approval for $3.95M Therapy, First for Sanfilippo Syndrome

The U.S. Food and Drug Administration (FDA) granted full approval to Ultragenyx Pharmaceutical's gene therapy, FAYUVI (UX111). This one-time intravenous...